Close

Impax Laboratories (IPXL) Reports Extended RYTARY PDUDA Date

September 17, 2014 9:03 AM EDT Send to a Friend
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. (Nasdaq: IPXL) announced that the U.S. Food and Drug Administration ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login